Biologists challenge Anthropic over Claude discovery claim

Anthropic recently announced that its newly established molecular biology lab achieved its first scientific breakthrough. Using a system of 950 Claude agents running for 21 hours, the AI flagged an uncatalogued repeating sequence pattern surrounding a known enzyme. The company compared the find to the biological structures that led to CRISPR gene-editing technology, suggesting the automated system had uncovered something of profound significance.

However, the announcement quickly drew skepticism from the scientific community. Biologist Lucas Harrington criticized the framing, arguing that identifying genetic clusters is merely automated grunt work rather than a true discovery, a sentiment endorsed by the CEO of Eli Lilly. Furthermore, University of Copenhagen biologist Mario Rodríguez Mestre revealed that his team had already identified the exact same pattern. Mestre, who had discussed his research with Claude, questioned if the model utilized his data, prompting him to stop using the chatbot despite Anthropic's denials.

This controversy highlights a growing tension between AI developers and researchers over what defines a scientific breakthrough. A similar debate emerged when OpenAI claimed its agents solved a million-dollar mathematics problem, only for skeptics to question the actual relevance of the solution and raise plagiarism concerns. While AI tools excel at narrowing down vast datasets—such as filtering 200,000 candidates to a viable few—critics argue that labeling these automated steps as independent discoveries oversells the technology.

For scientific practitioners, these incidents demonstrate that while LLMs are powerful tools for accelerating tedious data analysis, they are not yet independent researchers. Scientists must remain vigilant about data privacy when using commercial models like Claude for cutting-edge research. Ultimately, the rush by AI firms to claim independent discoveries may muddy the waters, making it harder for the public to recognize genuine, paradigm-shifting scientific milestones when they actually occur.